Founded in 2015, Paradromics Inc specializes in commercial physical and biological research, focusing on brain-computer interface (BCI) development. Their core mission is to restore or enhance neurological functions using advanced computing and AI. Paradromics aims to provide technology solutions for people with neurological and brain-related conditions, with their first clinical application designed to help severely motor-impaired individuals communicate, thus enabling social connection and restoring independence.
Paradromics has attracted notable investors and experts in the fields of neuroscience and technology. The company has achieved significant milestones in BCI technology, demonstrating high data-rate interfaces that could revolutionize how neurological conditions are treated. Their work has the potential to make a profound impact on the lives of individuals with severe motor impairments, offering new avenues for communication and independence.
